: ‘It’s not a magic pill’: What Merck’s antiviral pill could mean for vaccine hesitancy No Comments Uncategorized Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to print (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Tumblr (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pinterest (Opens in new window)Click to share on WhatsApp (Opens in new window)